Site Members can sign up for company wide alerts
Lawsuit Overview
December 19, 2014 (Shareholders Foundation) - An investor, who currently holds shares of Cubist Pharmaceuticals Inc (NASDAQ:CBST), filed a lawsuit in effort to halt the proposed takeover of Cubist Pharmaceuticals Inc by Merck for $102 per share. The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:CBST stockholders by agreeing to sell Cubist Pharma...
You must register (for free) or login to view the entire case.